Share
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
AMERICAN JOURNAL OF HEMATOLOGY
Campanella, A; Capasso, A; Heltai, S; Taccetti, C; Albi, E; Herishanu, Y; Haggenburg, S; Chatzikonstantinou, T; Doubek, M; Kättström, M; Giannopoulos, K; Simkovic, M; Moreno, C; Massaia, M; Bumbea, H; Alshemmari, S; Ranghetti, P; Perotta, E; Martini, F; Sant´Antonio, E; Colia, M; Combi, C; Levi, S; Kater, AP; Hazenberg, M; Nijhof, IS; Hofsink, Q; Demosthenous, C; Kotaskova, J; Zaleska, J; Vrbacky, F; Raya, AM; Bisogno, D; Tripoli, IE; Popov, VM; Roman, V; Stavroyianni, N; Karypidou, M; Scarano, E; Locatelli, M; Frenquelli, M; Scarfò, L; Stamatopoulos, K; Ghia, P, 2024: Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL. AMERICAN JOURNAL OF HEMATOLOGY , doi: 10.1002/ajh.27218
Research Groups:
CEITEC authors: